Expansion Cohorts in Early Development of Anticancer Agents
February 21, 2019 - Toronto ON CAXtalks
fbonilla@xtalks.com
Phone:1 416.977.6555
Join this webinar to learn about: The recent literature related to the use and design features of phase 1/2 trials and those with expansion cohorts The key points in the recent FDA draft guidance for industry The statistical caveats to have in mind when designing phase 1 trials with expansion cohorts, including early consideration of randomization and issues related to sample size calculation
This website uses cookies to ensure you get the best experience on our website. Learn more